Eloxx Pharmaceuticals, Inc. (ELOX) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.49 | +41.7% |
| 2024 | $-0.84 | +87.3% |
| 2023 | $-6.63 | +60.2% |
| 2022 | $-16.65 | +56.4% |
| 2021 | $-38.15 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.49 | +41.7% |
| 2024 | $-0.84 | +87.3% |
| 2023 | $-6.63 | +60.2% |
| 2022 | $-16.65 | +56.4% |
| 2021 | $-38.15 | — |